Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Vascular Biogen. Ord (VBLT)
Vascular Biogen. Ord (VBLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,670
  • Shares Outstanding, K 69,750
  • Annual Sales, $ 660 K
  • Annual Income, $ -32,300 K
  • 60-Month Beta 0.68
  • Price/Sales 26.82
  • Price/Cash Flow N/A
  • Price/Book 0.86
Trade VBLT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.42
  • Most Recent Earnings -0.03 on 05/15/23
  • Next Earnings Date 05/16/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 527.05% ( +26.30%)
  • Historical Volatility 77.09%
  • IV Percentile 68%
  • IV Rank 40.79%
  • IV High 1,258.78% on 04/18/23
  • IV Low 22.87% on 06/14/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 13
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 571
  • Open Int (30-Day) 560

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +832,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1761 +35.72%
on 05/17/23
0.3000 -20.33%
on 06/08/23
+0.0482 (+25.26%)
since 05/09/23
3-Month
0.1302 +83.56%
on 03/20/23
0.3000 -20.33%
on 06/08/23
+0.0885 (+58.80%)
since 03/09/23
52-Week
0.1009 +136.87%
on 12/19/22
2.2000 -89.14%
on 07/11/22
-1.2510 (-83.96%)
since 06/09/22

Most Recent Stories

More News
Vascular Biogenics: Q1 Earnings Snapshot

Vascular Biogenics: Q1 Earnings Snapshot

VBLT : 0.2390 (-5.53%)
INVESTIGATION ALERT: Halper Sadeh LLC Investigates KBAL, DSEY, VBLT, BTE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KBAL : 12.30 (-0.89%)
DSEY : 8.32 (-0.36%)
VBLT : 0.2390 (-5.53%)
BTE : 3.46 (unch)
Moore Kuehn Encourages DCT, PTRS, VBLT, and WAYN Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

DCT : 18.99 (unch)
PTRS : 6.08 (-0.33%)
VBLT : 0.2390 (-5.53%)
Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership

Aleph Farms , the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it has acquired a manufacturing facility in Modi’in, Israel, and certain related assets...

VBLT : 0.2390 (-5.53%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, BTE, ADMP, VBLT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ROCC : 39.03 (-0.28%)
BTE : 3.46 (unch)
ADMP : 2.05 (+0.49%)
VBLT : 0.2390 (-5.53%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vascular Biogenics Ltd. - VBLT

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

VBLT : 0.2390 (-5.53%)
VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Vascular Biogenics Ltd. operating as VBL...

VBLT : 0.2390 (-5.53%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFI, HRZN, VBLT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

INFI : 0.1801 (-3.28%)
HRZN : 12.06 (-1.39%)
VBLT : 0.2390 (-5.53%)
VBLT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Vascular Biogenics Ltd. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Vascular Biogenics Ltd. (NASDAQ: VBLT) and Notable Labs, Inc. is fair to Vascular shareholders. Per the merger agreement,...

VBLT : 0.2390 (-5.53%)
Vascular Biogenics (VBLT) Reports Q3 Loss, Tops Revenue Estimates

Vascular Biogenics (VBLT) delivered earnings and revenue surprises of -9.09% and 220.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

VBLT : 0.2390 (-5.53%)
SLHGF : 0.0190 (-2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vascular Biogenics Ltd. is a clinical stage biotechnology company. It is focused on the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead oncology candidate VB-111, is a gene-based biologic which is in Phase II clinical trials for the treatment...

See More

Key Turning Points

3rd Resistance Point 0.2965
2nd Resistance Point 0.2788
1st Resistance Point 0.2589
Last Price 0.2390
1st Support Level 0.2213
2nd Support Level 0.2036
3rd Support Level 0.1837

See More

52-Week High 2.2000
Fibonacci 61.8% 1.3981
Fibonacci 50% 1.1504
Fibonacci 38.2% 0.9028
Last Price 0.2390
52-Week Low 0.1009

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar